SCHEMBL5929127

SCHEMBL5929127

CCc1cccc(CC)c1-c1nc(-c2ccccc2)c(CN2CCCCC2C2CCCCC2)n1CCOC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.35
▸ HSD17B10 Q99714 10/20 0.35
▸ CYP3A4 P08684 7/20 0.35
▸ HPGD P15428 5/20 0.35
▸ KDM4E B2RXH2 5/20 0.35
▸ TSHR P16473 4/20 0.35
▸ CYP1A2 P05177 6/20 0.34
▸ CASP1 P29466 4/20 0.34
▸ CASP7 P55210 4/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CYP2C9 P11712 3/20 0.33
▸ HIF1A Q16665 2/20 0.33
▸ ADORA2A P29274 2/20 0.33
▸ ADORA1 P30542 2/20 0.33
▸ GLA P06280 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CD274 Q9NZQ7 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5929181 0.94 KMT2A (0.34) ALDH1A1HSD17B10CYP3A4HPGDKDM4E
SCHEMBL5928969 0.91 HCRTR1 (0.37) ALDH1A1HSD17B10HPGDKDM4EADORA1
SCHEMBL5929118 0.91 KMT2A (0.36) ALDH1A1CYP3A4KDM4EKMT2A
SCHEMBL5929248 0.86 KDM4E (0.33) ALDH1A1KDM4ETSHRMEN1KMT2A
SCHEMBL5929059 0.86 KDM4E (0.33) ALDH1A1KDM4ETSHRMEN1KMT2A
SCHEMBL5929000 0.82 CYP3A4 (0.34) ALDH1A1HSD17B10CYP3A4HPGDKDM4E
SCHEMBL5929137 0.82 ADORA2B (0.38) ALDH1A1HSD17B10HPGDKDM4ETSHR
SCHEMBL5929210 0.80 KDM4E (0.35) ALDH1A1HSD17B10CYP3A4HPGDKDM4E
SCHEMBL5929310 0.80 KMT2A (0.38) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL5929125 0.77 GAA (0.40) ALDH1A1KDM4ETSHRKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators NEUROGEN CORPORATION (US) 2006-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators C5AR1, C5AR2, C3AR1 ALDH1A1 3884/4885HSD17B10 4104/4885CYP3A4 983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback